Production (Stage)
Ondine Biomedical Inc.
OBIMF
$0.14
$0.00392.87%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 6.79M | 7.23M | 889.90K | 899.50K | 2.26M |
Total Receivables | 356.50K | 379.70K | 173.90K | 175.80K | 246.90K |
Inventory | 884.00K | 941.60K | 941.10K | 951.20K | 807.20K |
Prepaid Expenses | 331.50K | 353.10K | 238.20K | 240.70K | 166.60K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 110.50K | 117.70K | 111.10K | 112.30K | 118.90K |
Total Current Assets | 8.47M | 9.02M | 2.35M | 2.38M | 3.60M |
|
|||||
Total Current Assets | 8.47M | 9.02M | 2.35M | 2.38M | 3.60M |
Net Property, Plant & Equipment | 414.90K | 441.90K | 560.40K | 566.40K | 718.60K |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 25.70K | 27.40K | 26.30K | 26.60K | 26.50K |
Total Assets | 8.91M | 9.49M | 2.94M | 2.97M | 4.34M |
|
|||||
Total Accounts Payable | 1.10M | 1.17M | 1.38M | 1.39M | 1.03M |
Total Accrued Expenses | 2.91M | 3.10M | 1.14M | 1.15M | 1.32M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 116.80K | 124.40K | 256.50K | 259.20K | 289.30K |
Total Finance Division Other Current Liabilities | -- | -- | 157.10K | 158.80K | -- |
Total Other Current Liabilities | -- | -- | 157.10K | 158.80K | -- |
Total Current Liabilities | 4.13M | 4.40M | 2.93M | 2.96M | 2.64M |
|
|||||
Total Current Liabilities | 4.13M | 4.40M | 2.93M | 2.96M | 2.64M |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | 120.40K |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 4.13M | 4.40M | 2.93M | 2.96M | 2.76M |
|
|||||
Common Stock & APIC | 189.82M | 202.17M | 186.58M | 188.58M | 189.44M |
Retained Earnings | -198.38M | -211.28M | -200.27M | -202.42M | -201.67M |
Treasury Stock & Other | 13.33M | 14.20M | 13.71M | 13.85M | 13.81M |
Total Common Equity | 4.78M | 5.09M | 13.90K | 14.00K | 1.58M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 4.78M | 5.09M | 13.90K | 14.00K | 1.58M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 4.78M | 5.09M | 13.90K | 14.00K | 1.58M |
|